临床外科杂志 ›› 2025, Vol. 33 ›› Issue (12): 1283-1286.doi: 10.3969/j.issn.1005-6483.20241799

• 论著 • 上一篇    下一篇

血清透明质酸合成酶2、癌胚抗原、细胞角蛋白19水平对不同病理分型甲状腺癌中的诊断价值以及对术后复发的预测价值

王秋红 王贤 许华胜 翟振   

  1. 244100 安徽铜陵,铜陵市义安区人民医院普外科
  • 收稿日期:2024-11-08 出版日期:2025-12-20 发布日期:2025-12-20
  • 通讯作者: 王贤,Email:xiaowanghu01@163.com
  • 基金资助:
    安徽省重点研究与开发计划项目(202104j07010051)

The diagnostic value of serum HAS2,CEA and CK-19 in different pathologic types of thyroid carcinoma and the prediction value of postoperative recurrence

WANG Qiuhong,WANG Xian,XU Huasheng,ZHAI Zhen   

  1. Department of General Surgery,Yi'an District People's Hospital,Anhui,Tongling 244100,China
  • Received:2024-11-08 Online:2026-01-22 Published:2025-12-20

摘要: 目的 检测血清透明质酸合成酶2(HAS2)、癌胚抗原(CEA)、细胞角蛋白19(CK-19)在不同病理分型甲状腺癌中的表达情况,探讨其诊断价值以及对术后复发的预测价值。方法 2017年1月~2022年1月接受手术治疗的甲状腺癌病人202例,按分化情况分为分化组(164例)和未分化组(38例)。对所有病人进行随访,最短随访时间3个月,最长随访时间85个月,中位随访时间38个月。分化组存活157例,其中66例复发甲状腺癌,91例未复发;未分化组死亡37例,存活1例,存活的病人随访期间复发。收集病人临床资料,术前检测病人血清HAS2、CEA、CK-19水平,采用Spearman分析不同分型甲状腺癌血清HAS2、CEA、CK-19水平的相关性,受试者工作特征曲线(ROC)分析血清HAS2、CEA、CK19水平对未分化甲状腺癌的评估价值及对分化型甲状腺癌复发的预测价值。结果 分化组女性比例高于未分化组,TNM分期Ⅳ期病人比例、平均年龄、血清CEA、CK-19水平低于未分化组,差异有统计学意义(P<0.05),血清CEA、CK-19水平与未分化型甲状腺癌呈正相关(r=0.593、r=0.150,P<0.05),血清HAS2、CEA、CK19、三种指标联合评估未分化型甲状腺癌的曲线下面积(AUC)分别为0.609、0.859、0.595、0.879,约登指数分别为0.278、0.625、0.195、0.619。血清HAS2、CEA、CK19、三种指标联合预测分化型甲状腺癌复发的AUC分别为0.712、0.819、0.671、0.870,约登指数分别为0.374、0.557、0.311、0.616。结论 血清HAS2、CEA、CK-19对未分化甲状腺分型诊断及分化型甲状腺癌复发具有一定的评估价值,可作为辅助预测指标。

关键词: 透明质酸合成酶2; 癌胚抗原; 细胞角蛋白19; 甲状腺癌; 复发

Abstract: Objective To detect the expression of serum hyaluronic acid synthetase 2 (HAS2),carcinoembryonic antigen (CEA) and cytokeratin 19 (CK-19) in different pathologic types of thyroid carcinoma,and to explore their diagnostic value and prediction value for postoperative recurrence.Methods A total of 202 patients who received surgical treatment for thyroid cancer in our hospital from January 2017 to January 2022 were selected and divided into differentiated group (164 cases) and undifferentiated group (38 cases).All patients were followed up for a minimum of 3 months,a maximum of 85 months,and a median of 38 months.In the differentiated group,157 patients survived,of whom 66 had recurrent thyroid cancer and 91 did not.In the undifferentiated group, 37 cases died and 1 case survived. The surviving patients relapsed during the follow-up period.Clinical data of patients were collected,serum HAS2,CEA and CK-19 levels were detected,and the correlation between serum HAS2,CEA and CK-19 levels in different types of thyroid cancer was analyzed.Receiver operating characteristic curve (ROC) was used to analyze the value of serum HAS2,CEA and CK19 levels in the diagnosis of thyroid cancer classification and the prediction value of differentiated thyroid cancer recurrence.Results The proportion of females in the differentiated group was higher than that in the undifferentiated group.The proportion of TNM stage Ⅳ patients,mean age,serum CEA and CK-19 levels were lower than those in undifferentiated group (P<0.05).Serum CEA and CK-19 levels were positively correlated with undifferentiated thyroid cancer (r=0.593,r=0.150,P<0.05).The area under the curve (AUC) of HAS2,CEA,CK19 in the combined evaluation of undifferentiated thyroid cancer was 0.609,0.859,0.595,0.879,and the Yoden index was 0.278,0.625,0.195,0.619,respectively.The combined prediction AUC of HAS2,CEA,CK19 and three indexes for the recurrence of differentiated thyroid cancer was 0.712,0.819,0.671 and 0.870,respectively,and the Yoden index was 0.374,0.557,0.311 and 0.616,respectively.Conclusion Serum HAS2,CEA and CK-19 have certain values for the classification diagnosis of undifferentiated thyroid and the recurrence of differentiated thyroid cancer, and can be used as auxiliary predictive indicators.

Key words: hyaluronic acid synthase 2; carcinoembryonic antigen; cytokeratin 19; thyroid cancer; recrudescence

No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 胡志伟;汪忠镐;张玉;等. 腹腔镜Toupet胃底折叠术治疗干燥综合征合并严重胃食管反流病两例[J]. 临床外科杂志, 2016, 24(10): 766 .
[2] 李光焰;张安平;王祥峰;等. 直肠癌切除术后吻合口狭窄14例分析[J]. 临床外科杂志, 2016, 24(10): 772 .
[3] 胡小平;王志维;邓宏平;等. 改良全主动脉弓置换治疗老年Stanford A型主动脉夹层[J]. 临床外科杂志, 2016, 24(10): 777 .
[4] 陈绍站;许勇;李婧;等. 防旋股骨近端髓内针与股骨近端解剖锁定钢板治疗转子间骨折的疗效比较[J]. 临床外科杂志, 2016, 24(10): 787 .
[5] 刘琼;江辉. 喉罩在小儿舌系带矫正手术中的应用[J]. 临床外科杂志, 2016, 24(10): 792 .
[6] 危常鹏 . 原发性乳腺淋巴瘤一例[J]. 临床外科杂志, 2016, 24(10): 806 .
[7] 周振宇;汪路明;王一青;等. 肺部多发结节468例诊疗分析[J]. 临床外科杂志, 2016, 24(11): 865 .
[8] 沙米尔;丁佑铭;汪斌;等. 腹腔镜联合胆道镜两种术式治疗胆囊结石合并胆总管结石的临床疗效比较[J]. 临床外科杂志, 2016, 24(11): 872 .
[9] 邱远;杨桦. 营养支持治疗在重症患者肠功能维护中的作用[J]. 临床外科杂志, 2016, 24(12): 889 .
[10] 许静涌;韦军民. 外科重症患者规范化营养支持与治疗[J]. 临床外科杂志, 2016, 24(12): 892 .